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Background: To summary the procedure and experience of a novel surgical management for male infertility
secondary to midline prostatic cyst (MPC).
Methods: From February 2012 to February 2014, 12 patients were diagnosed with PMC by semen analysis, seminal
plasma biochemical analysis, transrectal ultrasonography (TRUS), and pelvic magnetic resonance imaging (MRI). All
patients underwent the transurethral unroofing of MPC using resectoscope, the dilation of ejaculatory duct, and
the irrigation of seminal vesicle using seminal vesiculoscope. All patients were followed up at least 3 months after
operation.
Results: Preoperative semen analyses of 12 patients showed oligoasthenozoospermia (5/12) or azoospermia (7/12),
low semen volume (0–1.9 mL), and low pH level (5.5-7.0). Preoperative seminal plasma biochemical analyses
showed reduced semen fructose. TURS and MRI revealed a cyst lesion located in the midline of prostatic. After
3 months follow up, the semen quality of 80% patients (4/5) with oligoasthenozoospermia improved obviously.
The spermatozoa were present in the semen in 5 of 7 cases with azoospermia. In one patient, the spermatozoa
occurred in the urine after ejaculation.
Conclusions: Surgical management using transurethral resectoscopy and seminal vesiculoscopy is effective,
minimally invasive, and safe for male infertility secondary to MPC.
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Male infertility affects about 8% of couples around the
world [1]. Midline prostatic cyst (MPC), a rare but surgi-
cally correctable disease, is deemed to cause ejaculatory
duct obstruction (EDO) which accounts for approxi-
mately 1-5% of male infertility [2]. Most MPCs are
nonsymptomatic. Semen analysis, transrectal ultrasonog-
raphy (TRUS) and pelvic magnetic resonance imaging
(MRI) can help to diagnose MPC. For treatment, cyst
puncture and simple endoscopic section are widely used.
However, the efficacy is often poor. The present study
shows a novel surgical management for male infertility
secondary to MPC.* Correspondence: zengjunwang@njmu.edu.cn
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Approval for this study was granted by the ethics
committee of Nanjing Medical University (China)
and informed written consent was received from all
participants.Patients
From February 2012 to December 2013, 12 patients were
recruited at Department of Urology, The First Affiliated
Hospital of Nanjing Medical University. The patients
were aged 18–40 years. All of them complained of infer-
tility 2–10 years after marriage. Two cases had hematos-
permia. Preoperative semen analyses of 12 patients
showed oligoasthenozoospermia (5/12) or azoospermia
(7/12), low semen volume (0–1.9 mL), and low pH level
(5.5-7.0). Preoperative seminal plasma biochemical ana-
lyses showed reduced semen fructose. TURS (Figure 1A)
and MRI (Figure 1B) revealed a cyst lesion located in the
midline prostate.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 The representative images of MPC. A, TRUS; B, pelvic MRI. The arrow indicates the cystic lesion.
Cheng et al. BMC Urology  (2015) 15:18 Page 2 of 5Procedures
The patients were placed under general anesthesia in the
dorsal lithotomy position. Transurethral unroofing of
MPC was performed using the F26 resectoscope. First,
the resectoscope was inserted into prostatic urethra for
preliminary visualization of the cyst (Figure 2A). Then
the ridgy posterior wall of the urethra was resected for
unroofing the MPC (Figure 2B and C). If the ejaculatoryFigure 2 Transurethral unroofing of MPC. A, the cyst is visualized throu
resected for unroofing the MPC. D, TURED is performed to make the ejacuduct opening was not obvious, transurethral resection of
the ejaculatory duct (TURED) was performed to make
the ejaculatory duct unobstructed (Figure 2D). Lastly,
the dilation of ejaculatory duct and the irrigation of sem-
inal vesicle were performed using F7 seminal vesiculo-
scope according to our previous report [3]. Under the
guidance of a zebra guidewire, the endoscope was
inserted into the ejaculatory ducts and seminal vesiclesgh the resectoscope. B and C, the ridgy posterior wall of the urethra is
latory duct unobstructed.
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sion dilation. The seminal vesicles usually contained the
congestive wall, and milky, yellow or pink vesicle fluid
filled with flocculent turbidity and dark blood clots
(Figure 3A). In some cases, seminal vesicle stones were
even found (Figure 3B). The seminal vesicles were irri-
gated using a levofloxacin solution (Figure 3C and D).
After operation, a urethral Foley catheter was remained
overnight. All patients were required to refrain from
ejaculation at least two weeks and followed up at least
3 months.
Outcomes analysis
Preoperative and postoperative serum sex hormone
levels were recorded. Preoperative and postoperative
semen qualities were monitored using a computer-
assisted semen analyzer (IVOS; Hamilton-Thorne,
Beverly, MA, U.S.).
Results
All operations were completed without conversion to
open surgery. There were no severe complications such
as rectal injury and urethral sphincter damage. The aver-
age length of hospitalization was 3 days. Serum sexFigure 3 Transurethral irrigation of seminal vesicle. A, seminal vesiculit
filled with flocculent turbidity and dark blood clots. B, seminal vesicle stone
levofloxacin solution.hormone levels of all patients prior to and after surgery
were within the normal range. The preoperative and
postoperative semen parameters were shown in Table 1.
After 3 months follow up, the semen quality of 80% pa-
tients (4/5) with oligoasthenozoospermia improved obvi-
ously. The spermatozoa were present in the semen in 5
of 7 cases with azoospermia. In one patient, the sperm-
atozoa occurred in the urine after ejaculation.
Discussion
MPC is previously thought to be Mullerian duct cyst,
causing EDO and male infertility through oppressing
ejaculatory duct [4]. Recent researches reveal that not all
cystic lesions are located in the midline prostate origin-
ate from Mullerian duct remnant. Some cases are just
the cystadenoma or the simple cyst of prostate [5]. Such
cyst in the midline prostate should be termed as pros-
tatic utricular cyst or cystic dilation of prostatic utricle,
depending on whether an outlet to the urethra exists.
Despite the embryologic or histological origin, MPC is
a surgically correctable disease. Many MPCs are asymp-
tomatic, or have some non-specific symptoms such as
perineal pain, hematospermia, and painful ejaculation.
One of the most important and serious outcomes causedis contains the congestive wall, and milky, yellow or pink vesicle fluid
s. C and D, the seminal vesicle is washed clearly and irrigated using a
Table 1 The preoperative and postoperative semen parameters of 12 cases
Preoperative Postoperative
Concentration (106/mL) Grade a + b (%) Concentration (106/mL) Grade a + b (%)
Oligoasthenozoospermia 1 11 33.3 45 60.0
Oligoasthenozoospermia 2 6 12.7 21 48.5
Oligoasthenozoospermia 3 15 26.1 73 66.5
Oligoasthenozoospermia 4 2 12.3 4 11.1
Oligoasthenozoospermia 5 9 22.4 50 59.6
Azoospermia 1 0 0 21 62.3
Azoospermia 2 0 0 17 52.3
Azoospermia 3 0 0 0 0
Azoospermia 4 0 0 32 68.7
Azoospermia 5 0 0 10 45.5
Azoospermia 6* 0 0 0 0
Azoospermia 7 0 0 43 57.9
*The spermatozoa occurred in the urine after ejaculation.
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Semen analysis of these patients often showed low
semen volume and pH level, reduced semen fructose,
oligoasthenozoospermia, and even azoospermia.
Vasoseminal vesiculography is the golden standard for
diagnosis. Percutaneous testicular sperm aspiration
(PTSA) is helpful to identify the type of MPC. However,
these methods are invasive and complicated. TURS is
preferred for simple and noninvasive characteristics. It
can offer greater details about the relationship of pros-
tatic, seminal vesicle, and ejaculatory duct [6]. Pelvic
MRI not only clearly shows the anatomy of prostatic,
seminal vesicle, and ejaculatory duct, but also helps to
judge the nature of cyst fluid [7].
The treatment for MPC is still controversial. Some re-
searchers claimed that treatment should only be per-
formed on symptomatic or infertile patients since almost
60% of cases with MPC did not experience any cyst-
related symptoms or fertility impairment [8]. Invasive
procedures include transperineal or transrectal puncture
and endoscopic section of the utricle meatu [9]. How-
ever, puncture therapy has a high recurrence rate while
endoscopic incision faces persistent post-operative se-
vere oligozoospermia or azoospermia [10]. We speculate
that MPC may cause to seminal vesiculitis and further
promote the abnormal semen quality through oppres-
sing ejaculatory duct and causing semen stasis. There-
fore, the dilation of ejaculatory duct and the irrigation
of seminal vesicle using seminal vesiculoscope were
performed after transurethral unroofing of the cyst in
present study. A previous study achieved a better re-
sult for MPC with male infertility using transurethral
endoscopic incision, in which a pregnancy rate was
30.8% (8/26) [10]. However, other reports showed apoor efficacy of unroofing of the cyst [11]. The
present study is delightful with a pregnancy rate of
41.7% (5/12) and an obviously improved semen qual-
ity of 75% (9/12). One patient with azoospermia had
spermatozoa in the urine after ejaculation. For the
two patients of poor efficacy, seminal vesicle impair-
ment due to long term semen stasis might cause in-
adequate transfer of semen quality [12]. In conclusion,
our data showed that the novel surgical management is
effective, minimally invasive, and safe for male infertility
secondary to MPC.
The followings are our endoscopic experiences. Some-
times, it is difficult to find the opening since the ejaculatory
duct is oppressed by MPC or covered by inflammatory
tissues [3,13]. Increasing the velocity of water perfusion
and using a zebra guidewire as the guidance are helpful to
find the openings. Otherwise, vas deferens puncture and
injection of methylene blue, combined with the transureth-
ral endoscope, are helpful to observe the ejaculatory duct
openings. After observing the seminal vesicle lumen care-
fully, appropriate therapies can be implemented. Inflamma-
tory semen can be treated with antibiotics irrigation into
seminal vesicle. Stones can be removed through holmium
laser lithotripsy and forceps.
Conclusions
Surgical management using transurethral resectoscopy
and seminal vesiculoscopy has good clinical outcomes for
improving the semen quality. It is effective, minimally inva-
sive, and safe for male infertility secondary to MPC.
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